Avandia, a medication used to fight type 2 diabetes, has been identified as a heart risk. The risks were reported in a study last week and confirmed by the government’s preliminary evaluation. The FDA would like to wait for the results of a study that will not conclude for two years, which could put millions more at risk. Critics of the FDA and Avandia complain that two years is too long to wait when lives are at risk. The initial study suggests that as many as 60,000 to 10,000 heart attacks might be linked to the use of Avandia from the time it appeared on the market eight years ago. Diabetics are especially susceptible to heart complication; two-thirds of diabetics die from heart problems. The FDA and diabetes experts are advising users of the drug to talk to their doctors before discontinuing the drug to prevent losing control of blood-sugar levels. Product liability law provides compensation for those who may have been affected by the use of this drug.
Click here to view the full article